As of Oct 26
| +1.09 / +0.69%|
The 18 analysts offering 12-month price forecasts for Amgen have a median target of 191.50, with a high estimate of 209.00 and a low estimate of 157.00. The median estimate represents a +20.45% increase from the last price of 158.99.
The current consensus among 23 polled investment analysts is to Buy stock in Amgen. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.